Other studies have revealed that circulating Gal-3 that is released from metastatic cells promotes osteoclast differentiation [22,23]; nonetheless, other studies demonstrate that a secreted form of Gal-3, released from breast cancer cells, blocks the differentiation of bone metastasis through the deregulation of Notch signaling [21]. Here, LGALS3 is linked to breast carcinoma.